Generic Name: IVIg Intravenous Immuno Globulin
See also: Gammaglobulin (IVIg)
Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immunodeficiency disorders, B-cell chronic lymphocytic leukemia, inflammatory demyelinating disorders. Off label uses include Guillain-Barré, Multiple Sclerosis, and myasthenia gravis.
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Peripheral Neuropathy (neuritis) | 1 | 0 |
See 1 patient currently taking IVIg Intravenous Immuno Globulin
Mouse over the table for more information
| 69 mg monthly | ||
|---|---|---|
1
|
||
Currently Taking IVIg Intravenous Immuno Globulin
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 20, 2010.